1500011H22Rik Activators are a unique ensemble of chemical compounds that indirectly boost the functional activity of the protein through various intricate signaling pathways. Forskolin serves to heighten intracellular cAMP levels, potentially leading to the activation of PKA, which could then phosphorylate proteins within the same pathways as 1500011H22Rik, indirectly enhancing its role. Genistein, by inhibiting tyrosine kinases, removes competitive inhibitors from signaling cascades, which may result in the upregulation of 1500011H22Rik's functional activity. The modulation of protein kinase C by PMA and the alterations in lipid signaling induced by sphingosine-1-phosphate may further support the activity of 1500011H22Rik by changing the phosphorylation state of the protein or its interacting partners. Similarly, PI3K inhibitors such as LY294002 and Wortmannin, by altering AKT signaling, may provide a conducive environment for the activation of 1500011H22Rik, as well as EGCG through its kinase inhibition properties.
In addition, the kinase inhibitors SB203580 and U0126 could foster an environment where the functional activity of 1500011H22Rik is enhanced by inhibiting competing signaling molecules like p38 MAPK and MEK1/2, respectively. This allows for a shift in the equilibrium of cellular signaling towards pathways where 1500011H22Rik is a critical player. Intracellular calcium modulators, such as Thapsigargin and A23187, also play a significant role by raising calcium levels within the cell, thereby activating calcium-dependent pathways that can enhance the activity of 1500011H22Rik. Lastly, Staurosporine, despite being a broad-spectrum kinase inhibitor, might inadvertently lead to the selective activation of pathways involving 1500011H22Rik by lifting kinase-imposed restraints on 1500011H22Rik-associated processes. These activators, through their targeted biochemical actions, collectively support the enhancement of 1500011H22Rik's activity, thus amplifying its role within the cell without directly increasing its expression or requiring direct binding to the protein.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein acts as a tyrosine kinase inhibitor, which may reduce competitive signaling and indirectly upregulate the functional activity of 1500011H22Rik through pathways that are less inhibited as a result. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates PKC which could result in the phosphorylation of proteins within pathways where 1500011H22Rik is involved, thus leading to its indirect functional enhancement. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 inhibits PI3K, altering downstream AKT signaling, which may have a permissive effect on the activation of 1500011H22Rik by altering signaling dynamics that 1500011H22Rik is part of. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another PI3K inhibitor that by reducing PI3K activity can indirectly enhance the activity of 1500011H22Rik by affecting the same pathways as LY294002. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 selectively inhibits p38 MAPK, potentially shifting the signaling balance to favor other pathways including those where 1500011H22Rik functions, and thereby enhancing its activity. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate modulates sphingolipid signaling pathways which might affect the functional activity of 1500011H22Rik by influencing the lipid signaling milieu it operates within. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin raises intracellular calcium levels, potentially activating calcium-dependent signaling pathways that enhance the activity of 1500011H22Rik. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine, as a broad-spectrum protein kinase inhibitor, might selectively activate pathways that involve 1500011H22Rik by eliminating specific kinase-mediated inhibitions. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG, a kinase inhibitor, may reduce competitive signaling, potentially allowing for the enhancement of pathways where 1500011H22Rik is involved. | ||||||